Schedule 13G ownership disclosure
DIANTHUS THERAPEUTICS INC COM
Common Stock, par value $0.001 per share · CUSIP: 252828108
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Vestal Point Capital, LP
Shares: 3,200,000.00 · Class: 9.95%
- Ryan Wilder
Shares: 3,200,000.00 · Class: 9.95%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-003605
- Form type
- SCHEDULE 13G/A
- Filer
- Dianthus Therapeutics, Inc. /DE/
- CIK
- CIK 1690585
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership